TMBIM4 and COVID-19: In addition, S1R has other antiviral effects, including reducing platelet aggregation, reducing mast cell degeneration, interfering with endolysosomal virus transport, regulating myositol requiring enzyme 1α driven inflammation and increasing melatonin levels [26], which may be important mechanisms influencing COVID-19 treatment.